At present, there are no data on alterations on the cerebral expression of CD200 and CD200R1 in PD, but polymorphisms in the promoter of the CD200R1 gene resulting in a reduced transcriptional activity have been associated with a higher risk of PD [46]. The gene discussed is CD200; the disease is Parkinson disease.